Curaleaf Keeps New Jersey Adult-Use Licenses

NJ CRC Board Reverses Itself and Fully Approves Curaleaf’s Adult Use License Renewals After Legal Challenge

NEW YORK, April 17, 2023 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced that today, Monday, April 17th, the Board of the New Jersey Cannabis Regulatory (CRC) reversed itself and voted to approve Curaleaf’s adult use cannabis licenses.

The CRC Board’s decision came after first voting to vacate their decision from Thursday, April 13th, when they attempted to deny Curaleaf’s adult use license renewals.

Today’s decision by the CRC Board to vacate their unprecedented action last week is an incredible victory for our 500 NJ team members and vindication for what we knew all along: Curaleaf is in good standing with the CRC and has fulfilled every requirement necessary for the renewal of our licenses.

Curaleaf CEO Matt Darin

I am incredibly proud of and grateful to every one of the hundreds of dedicated team members who showed up today, not just for their jobs and livelihoods, but for a better, safer cannabis industry in New Jersey.

In previously attempting not to renew Curaleaf’s adult use licenses, the CRC Board had disregarded the Commission’s staff recommendation to renew Curaleaf’s adult use licenses and the fact that the company has no pending violations.

As part of the approval, Curaleaf will be providing the Commission with additional information regarding its labor practices and confirm its ongoing compliance with New Jersey law.

This decision by the Board is a victory for Curaleaf, a company that has proudly generated tens of millions of tax dollars for the State, invested upwards of $75M more to support its cannabis industry, and supplied cannabis products to nearly all of New Jersey’s licensed dispensaries, including social equity license holders. Curaleaf remains open for business and will continue working collaboratively with the CRC Board and its staff to ensure our good standing in the State of New Jersey.

Curaleaf Chairman Boris Jordan

About Curaleaf Holdings

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, Curaleaf currently operates in 19 states with 151 dispensaries and employs nearly 5,500 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter